Vericel (VCEL) News Today $52.00 -2.31 (-4.25%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$52.00 +0.01 (+0.01%) As of 02/21/2025 06:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Vericel (VCEL) to Release Earnings on ThursdayVericel (NASDAQ:VCEL) will be releasing earnings before the market opens on Thursday, February 27. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=666287)February 21 at 1:32 AM | marketbeat.comNew York State Common Retirement Fund Has $46.94 Million Stock Holdings in Vericel Co. (NASDAQ:VCEL)New York State Common Retirement Fund decreased its position in shares of Vericel Co. (NASDAQ:VCEL - Free Report) by 0.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 854,902 shares of the biotechnology coFebruary 20 at 4:37 AM | marketbeat.comKornitzer Capital Management Inc. KS Purchases Shares of 12,000 Vericel Co. (NASDAQ:VCEL)Kornitzer Capital Management Inc. KS purchased a new stake in Vericel Co. (NASDAQ:VCEL - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 12,000 shares of the biotechnology company's stock, valued at approximaFebruary 20 at 4:19 AM | marketbeat.comTimesSquare Capital Management LLC Acquires 42,015 Shares of Vericel Co. (NASDAQ:VCEL)TimesSquare Capital Management LLC increased its holdings in Vericel Co. (NASDAQ:VCEL - Free Report) by 7.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 632,160 shares of the biotechnology company's stoFebruary 19 at 6:37 AM | marketbeat.comAllspring Global Investments Holdings LLC Cuts Stock Holdings in Vericel Co. (NASDAQ:VCEL)Allspring Global Investments Holdings LLC lowered its stake in shares of Vericel Co. (NASDAQ:VCEL - Free Report) by 35.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 261,073 shares of the biotechnoloFebruary 18, 2025 | marketbeat.comCongress Asset Management Co. Grows Stock Holdings in Vericel Co. (NASDAQ:VCEL)Congress Asset Management Co. grew its holdings in shares of Vericel Co. (NASDAQ:VCEL - Free Report) by 12.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,454,139 shares of the biotechnology company's stocFebruary 16, 2025 | marketbeat.comLegato Capital Management LLC Sells 8,144 Shares of Vericel Co. (NASDAQ:VCEL)Legato Capital Management LLC reduced its holdings in shares of Vericel Co. (NASDAQ:VCEL - Free Report) by 58.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 5,720 shares of the biotechnology company's stocFebruary 15, 2025 | marketbeat.comVericel director Kevin McLaughlin sells shares worth $388,250February 14, 2025 | msn.comVericel to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 27, 2025February 13, 2025 | globenewswire.comVericel's principal accounting officer sells $67,693 in stockFebruary 8, 2025 | msn.comVericel director Robert Zerbe sells $156,250 in stockFebruary 8, 2025 | msn.comVericel Co. (NASDAQ:VCEL) Insider Sells $67,693.08 in StockFebruary 8, 2025 | insidertrades.comVericel Co. (NASDAQ:VCEL) Insider Jonathan Siegal Sells 1,092 SharesVericel Co. (NASDAQ:VCEL - Get Free Report) insider Jonathan Siegal sold 1,092 shares of the company's stock in a transaction that occurred on Wednesday, February 5th. The shares were sold at an average price of $61.99, for a total value of $67,693.08. Following the completion of the transaction, the insider now directly owns 1,206 shares in the company, valued at $74,759.94. This trade represents a 47.52 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.February 7, 2025 | marketbeat.comRobert L. Md Zerbe Sells 2,500 Shares of Vericel Co. (NASDAQ:VCEL) StockVericel Co. (NASDAQ:VCEL - Get Free Report) Director Robert L. Md Zerbe sold 2,500 shares of the stock in a transaction dated Wednesday, February 5th. The stock was sold at an average price of $62.50, for a total value of $156,250.00. Following the sale, the director now directly owns 26,595 shares in the company, valued at $1,662,187.50. This trade represents a 8.59 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link.February 7, 2025 | marketbeat.comVericel (NASDAQ:VCEL) Hits New 52-Week High - Still a Buy?Vericel (NASDAQ:VCEL) Sets New 1-Year High - Here's WhyFebruary 5, 2025 | marketbeat.comVericel price target raised to $67 from $64 at CanaccordFebruary 4, 2025 | markets.businessinsider.comConestoga Capital Advisors LLC Sells 6,300 Shares of Vericel Co. (NASDAQ:VCEL)Conestoga Capital Advisors LLC trimmed its position in shares of Vericel Co. (NASDAQ:VCEL - Free Report) by 0.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,069,430 shares of the biotechnology company's stock aftFebruary 3, 2025 | marketbeat.comVericel (NASDAQ:VCEL) Price Target Raised to $67.00 at Canaccord Genuity GroupCanaccord Genuity Group boosted their price target on shares of Vericel from $64.00 to $67.00 and gave the company a "buy" rating in a report on Monday.February 3, 2025 | marketbeat.comVericel Co. (NASDAQ:VCEL) Receives Consensus Rating of "Buy" from BrokeragesShares of Vericel Co. (NASDAQ:VCEL - Get Free Report) have been given an average recommendation of "Buy" by the seven research firms that are currently covering the company, MarketBeat Ratings reports. Seven research analysts have rated the stock with a buy recommendation. The average twelve-monthFebruary 2, 2025 | marketbeat.comSG Americas Securities LLC Lowers Stock Holdings in Vericel Co. (NASDAQ:VCEL)SG Americas Securities LLC lessened its holdings in Vericel Co. (NASDAQ:VCEL - Free Report) by 60.4% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 9,706 shares of the biotechnology company's stock after selling 14,780 shares during the peFebruary 1, 2025 | marketbeat.comJonathan Siegal Sells 3,908 Shares of Vericel Co. (NASDAQ:VCEL) StockJanuary 31, 2025 | insidertrades.comInsider Selling: Vericel Co. (NASDAQ:VCEL) Insider Sells 3,908 Shares of StockVericel Co. (NASDAQ:VCEL - Get Free Report) insider Jonathan Siegal sold 3,908 shares of Vericel stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $61.99, for a total transaction of $242,256.92. Following the transaction, the insider now directly owns 1,206 shares in the company, valued at $74,759.94. This represents a 76.42 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.January 30, 2025 | marketbeat.comVCEL Stock Touches 52-Week High at $61.5 Amidst Strong GrowthJanuary 29, 2025 | msn.comVericel (NASDAQ:VCEL) Sets New 12-Month High - Time to Buy?Vericel (NASDAQ:VCEL) Hits New 12-Month High - Time to Buy?January 28, 2025 | marketbeat.comPark Avenue Securities LLC Buys Shares of 5,099 Vericel Co. (NASDAQ:VCEL)Park Avenue Securities LLC acquired a new position in shares of Vericel Co. (NASDAQ:VCEL - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 5,099 shares of the biotechnology company's stock, valued at appJanuary 26, 2025 | marketbeat.comVericel (NASDAQ:VCEL) Stock Passes Above 200 Day Moving Average - Here's What HappenedVericel (NASDAQ:VCEL) Stock Passes Above Two Hundred Day Moving Average - What's Next?January 25, 2025 | marketbeat.comWhat is HC Wainwright's Forecast for Vericel Q3 Earnings?Vericel Co. (NASDAQ:VCEL - Free Report) - Equities research analysts at HC Wainwright lowered their Q3 2025 earnings estimates for shares of Vericel in a report released on Wednesday, January 15th. HC Wainwright analyst S. Ramakanth now forecasts that the biotechnology company will post earningsJanuary 17, 2025 | marketbeat.comOptimistic Long-Term Growth Outlook for Vericel Despite Recent SetbacksJanuary 17, 2025 | markets.businessinsider.comStocks Climb Before the Open on Fed Rate Cut Bets, U.S. Economic Data and Earnings on TapJanuary 16, 2025 | msn.comFY2024 Earnings Estimate for Vericel Issued By HC WainwrightVericel Co. (NASDAQ:VCEL - Free Report) - Research analysts at HC Wainwright decreased their FY2024 earnings estimates for shares of Vericel in a research report issued on Wednesday, January 15th. HC Wainwright analyst S. Ramakanth now anticipates that the biotechnology company will earn $0.16 peJanuary 16, 2025 | marketbeat.comVericel’s Strong Growth Prospects and MACI Product Drive Buy Rating Amid Positive Revenue Trajectory and Future Expansion PlansJanuary 15, 2025 | markets.businessinsider.comTD Cowen Remains a Buy on Vericel (VCEL)January 15, 2025 | markets.businessinsider.comVericel (NASDAQ:VCEL) Shares Gap Down - Time to Sell?Vericel (NASDAQ:VCEL) Shares Gap Down - Should You Sell?January 15, 2025 | marketbeat.comVericel (NASDAQ:VCEL) Receives "Overweight" Rating from StephensStephens reiterated an "overweight" rating and issued a $65.00 price objective on shares of Vericel in a report on Wednesday.January 15, 2025 | marketbeat.comHC Wainwright Reaffirms "Buy" Rating for Vericel (NASDAQ:VCEL)HC Wainwright reiterated a "buy" rating and issued a $60.00 target price on shares of Vericel in a research note on Wednesday.January 15, 2025 | marketbeat.comVericel Shares Fall 10% After 4Q Forecast Misses EstimatesJanuary 15, 2025 | marketwatch.comVericel's preliminary Q4 revenue falls short of analyst expectations; shares fall 11% post marketJanuary 15, 2025 | uk.investing.comClosing Bell Movers: Vericel down 11% after Q4 pre-announcementJanuary 15, 2025 | msn.comVericel sees Q4 revenue $75.2M-$75.7M, consensus $77.9MJanuary 15, 2025 | markets.businessinsider.comVericel down 10% at $52.67 after below-consensus Q4 pre-announcementJanuary 15, 2025 | markets.businessinsider.comVericel Announces Preliminary 2024 Financial Results, 2025 Financial Guidance and Increased Mid-Term Profitability TargetsJanuary 14, 2025 | globenewswire.comJPMorgan Chase & Co. Has $19.08 Million Stake in Vericel Co. (NASDAQ:VCEL)JPMorgan Chase & Co. lowered its holdings in Vericel Co. (NASDAQ:VCEL - Free Report) by 5.8% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 451,620 shares of the biotechnology company's stock after selling 28,009 shJanuary 10, 2025 | marketbeat.comVericel Co. (NASDAQ:VCEL) Receives Average Recommendation of "Buy" from BrokeragesVericel Co. (NASDAQ:VCEL - Get Free Report) has been assigned an average rating of "Buy" from the seven research firms that are currently covering the company, Marketbeat Ratings reports. Six investment analysts have rated the stock with a buy recommendation and one has given a strong buy recommenJanuary 8, 2025 | marketbeat.comVericel (VCEL) Gets a Buy from TD CowenJanuary 8, 2025 | markets.businessinsider.comVericel (NASDAQ:VCEL) Stock Price Passes Above 200-Day Moving Average - Time to Sell?Vericel (NASDAQ:VCEL) Shares Cross Above 200-Day Moving Average - Here's What HappenedJanuary 8, 2025 | marketbeat.comVericel Co. (NASDAQ:VCEL) Shares Sold by Kopp Family Office LLCKopp Family Office LLC lessened its stake in Vericel Co. (NASDAQ:VCEL - Free Report) by 18.5% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 372,948 shares of the biotechnology company's stock after selling 84,730 sharesDecember 31, 2024 | marketbeat.comVericel Co. (NASDAQ:VCEL) Shares Sold by Principal Financial Group Inc.Principal Financial Group Inc. cut its holdings in Vericel Co. (NASDAQ:VCEL - Free Report) by 26.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 251,858 shares of the biotecDecember 31, 2024 | marketbeat.comVericel Co. (NASDAQ:VCEL) Shares Acquired by Geode Capital Management LLCGeode Capital Management LLC lifted its holdings in shares of Vericel Co. (NASDAQ:VCEL - Free Report) by 0.8% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,154,053 shares of the biotechnology company's stock after purchasing an addDecember 24, 2024 | marketbeat.comVericel (NASDAQ:VCEL) Upgraded at StockNews.comStockNews.com raised shares of Vericel from a "sell" rating to a "hold" rating in a report on Tuesday.December 24, 2024 | marketbeat.comBarclays PLC Purchases 66,082 Shares of Vericel Co. (NASDAQ:VCEL)Barclays PLC raised its position in Vericel Co. (NASDAQ:VCEL - Free Report) by 145.4% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 111,527 shares of the biotechnology company's stock after purchasing an additional 66,082 shares durDecember 22, 2024 | marketbeat.com Get Vericel News Delivered to You Automatically Sign up to receive the latest news and ratings for VCEL and its competitors with MarketBeat's FREE daily newsletter. Email Address VCEL Media Mentions By Week VCEL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VCEL News Sentiment▼1.470.60▲Average Medical News Sentiment VCEL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VCEL Articles This Week▼65▲VCEL Articles Average Week Get Vericel News Delivered to You Automatically Sign up to receive the latest news and ratings for VCEL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PCVX News Today SRPT News Today QGEN News Today ASND News Today ROIV News Today RVMD News Today LEGN News Today BBIO News Today AXSM News Today BPMC News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VCEL) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vericel Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vericel With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
